Antitumor activity via inhibition of glycosphingolipid biosynthesis
- 30 November 1987
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 38 (1-2), 23-30
- https://doi.org/10.1016/0304-3835(87)90196-0
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progressionFEBS Letters, 1986
- Glucosylceramide and the level of the glucosidase‐stimulating proteinsLipids, 1986
- Gangliosides and neutral glycosphingolipids of normal tissue and oat cell carcinoma of human lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- GlycosphingolipidsScientific American, 1986
- Association of Gaucher's Disease and lymphoid malignancy in 2 childrenScandinavian Journal of Haematology, 1985
- Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and b-cell proliferations?Cancer, 1984
- GQlb, a Bioactive Ganglioside that Exhibits Novel Nerve Growth Factor (NGF)Like Activities in the Two Neuroblastoma Cell LinesThe Journal of Biochemistry, 1983
- Lipolysis induction in adipocytes by a protein from tumor cellsJournal of Cellular Biochemistry, 1982
- Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brainChemistry and Physics of Lipids, 1980
- EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTSThe Journal of Experimental Medicine, 1963